EVENTS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021
– Nonclinical data for STRO-002 and STRO-001 are shared in two oral presentations at the 63rd American Society of Hematology Annual Meeting SOUTH SAN FRANCISCO, Calif, Dec. 13, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development...
4th Annual Evercore ISI HeathCONx Conference – Presentation
Webcast, Nov 30, 2021 at 10:05am EST Download Presentation, Click Here
Piper Sandler 33rd Annual Healthcare Conference – Presentation
Webcast, Nov 22, 2021 at 10:00am EST Download Presentation, Click here
Sutro Biopharma to Participate in Two Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
Jefferies London Healthcare Conference – Presentation
Webcast: Nov 18, 2021 at 3:00am EST Download: Click Here
Stifel 2021 Virtual Healthcare Conference – Presentation
Webcast: Nov 15, 2021 at 1:20pm EST Download: Click Here
Credit Suisse 30th Annual Healthcare Conference – Presentation
Webcast, Nov 10, 2021 at 4:20pm EST Download Presentation, Click Here
Sutro Biopharma to Participate in Three Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
2021 Wells Fargo Virtual Healthcare Conference – Presentation
Webcast, Sept 9, 2021 at 3:20pm EST
Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 1, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...